 Elusys Therapeutics Inc, the merger partner for Heat Biologics Inc HTBX, has finalized a contract with the Office of the Assistant Secretary for Preparedness and Response ASPR in the U.S. Department of Health and Human Services HHS for the continued supply of ANTHIM obiltoxaximab, an anthrax antitoxin. ALERT Nic Chahine shares his Bear Market Beating options trading strategy. 